Screening for obstructive sleep apnoea in professional drivers

Professional drivers show a higher prevalence of obstructive sleep apnoea (OSA) compared with the general population. Furthermore, there is concern about the association between OSA and car crash risk given that drivers with OSA show an increased risk for car accidents. Despite this risk, OSA is often underdiagnosed and undertreated in this population, mainly due to lack of appropriate screening and sleep study referrals. Polysomnography (PSG), the gold standard test, is inappropriate for systematic screening because of its high expense, complexity and relative inaccessibility in this population. Therefore, there is a strong demand for good screening tools, including both subjective and objective data that may assist in early identification of possible OSA among professional drivers and, thus, aid in PSG examination referral and OSA management in an accredited sleep centre. However, there is considerable disagreement over screening methods and criteria for triggering a sleep study referral in different countries. There is also a strong need for further research in the area of OSA screening of commercial drivers in order to improve the diagnostic accuracy of screening tools and ensure that patients with OSA are accurately identified. KEY POINTS: Obstructive sleep apnoea (OSA) is often undiagnosed and undertreated in professional drivers. Professional drivers often under-report and are reluctant to report OSA symptoms. Barriers to OSA diagnosis include appropriate screening and sleep study referrals. Screening tools including both subjective and objective data may assist in early identification of possible OSA among professional drivers. EDUCATIONAL AIMS: To evaluate screening instruments currently used to identify OSA risk in professional drivers. To provide guidance for developing an assessment strategy for OSA by professional driver medical examiners.